Trulieve Announces Grand Opening of Medical Dispensary in Fernandina Beach, Florida

Trulieve Announces Grand Opening of Medical Dispensary in Fernandina Beach, Florida Jun 01, 2024 TALLAHASSEE, Fla., June 01, 2024 (GLOBE NEWSWIRE) -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the grand opening of its newest medical cannabis dispensary in Fernandina Beach, Florida. Located at 1527 Sadler Road, the dispensary will open its doors on Saturday, June 1, 2024, at 9:00 AM ET. This is Trulieve’s 74th store in Florida and 196th nationwide, providing patients with expanded access to medical cannabis, along with one-on-one consultations to help them find the right medication. As always, all registered patients will receive a 25% discount at this location on grand opening day. WHAT: Trulieve Fernandina Beach Grand Opening WHERE: 1527 Sadler Road, Fernandina Beach, FL 32034 WHEN: Saturday, June 1, 2024, at 9:00 AM ET Festivities will include partner giveaways, music, food trucks, deals and special discounts. Trulieve employees will be on site to register new patients and answer questions. Trulieve’s retail employees are trained to provide personalized support and individualized consultations to ensure patients are properly dosed and equipped with the knowledge to use medical cannabis safely and effectively. Trulieve provides patients with the largest selection of THC and CBD products in a variety of forms, including smokable flower, concentrates, edibles, capsules, syringes, tinctures, topical creams, vaporizers, and more. Patients can choose to shop in-store or conveniently order online with same-day delivery or in-store pickup. Trulieve is committed to expanding access to medical cannabis to communities across Florida. For more information, or to find a location near you, please visit Trulieve.com. About Trulieve Trulieve is an industry leading, top-performing cannabis company and multi-state operator in the U.S., with a mission to provide safe, accessible and reliable products and services to its patients and customers. It is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. Please visit Trulieve.com to learn more. Investor Contact Christine Hersey, Director of Investor Relations +1 (424) 597-0275 [email protected] Media Contact Nicole Miller, Director of Communications +1 (404) 736-2001 [email protected]